← Open Payments lookup

RUTH FELDMAN: Open Payments

NPI 1255930624 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,055 in 98 payments from 15 companies in 2025. Trend: 2023 $1,503 · 2024 $2,153 · 2025 $2,055

Food & beverage: $2,055
CompanyPaymentsAmount
ABBVIE INC.19$404
Lundbeck LLC20$341
Axsome Therapeutics, Inc.13$306
Neurocrine BioSciences, Inc.8$224
Alkermes, Inc.12$221
Neos Therapeutics, LP5$113
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$111
Vanda Pharmaceuticals Inc.3$84
Bausch Health US, LLC4$79
Teva Pharmaceuticals USA, Inc.2$50

Products named: VRAYLAR, Auvelity, INGREZZA, ARISTADA, REXULTI, Adzenys XR-ODT, CAPLYTA, ABILIFY ASIMTUFII.

Industry payments across MD — which companies pay providers there.